US 9066957
Dry powder inhaler
granted A61KA61K31/137A61K31/56
Quick answer
US patent 9066957 (Dry powder inhaler) held by Teva Branded Pharmaceutical Products R&D, Inc. expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Branded Pharmaceutical Products R&D, Inc.
- Grant date
- Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/137, A61K31/56, A61K31/569, A61K31/57